Kronos Bio Inc

KRON
1,03
0,03 (3,00%)
30 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/4/202422:01GLOBEKronos Bio to Present Clinical Update on Phase 1/2 Trial of..
21/3/202412:05GLOBEKronos Bio Reports Recent Business Progress and..
07/3/202422:05EDGAR2Form 8-K - Current report
07/3/202422:05GLOBEKronos Bio Announces Restructuring to Focus Resources on..
05/3/202422:44GLOBEKronos Bio To Present Three Posters at AACR 2024 Annual..
05/3/202413:00EDGAR2Form 8-K - Current report
27/2/202422:05GLOBEKronos Bio Announces Participation in 44th Annual Cowen..
24/2/202402:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202402:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
24/2/202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202402:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
25/1/202414:05EDGAR2Form 8-K - Current report
06/1/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202400:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202400:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:06GLOBEKronos Bio Announces Pipeline Update and p300 KAT Inhibitor..
13/12/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202314:00GLOBEKronos Bio Announces Participation in H.C. Wainwright 4th..
27/11/202322:05GLOBEKronos Bio Announces Participation in 35th Annual Piper..
13/11/202322:08EDGAR2Form 8-K - Current report
13/11/202322:05GLOBEKronos Bio Reports Recent Business Progress and..
13/11/202322:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:11EDGAR2Form 8-K - Current report
02/11/202321:05GLOBEKronos Bio Announces Plan to Optimize Resource Allocation,..
02/11/202317:00GLOBEKronos Bio Presents Positive Preliminary Data from the Phase..
27/10/202314:00GLOBEKronos Bio To Present Positive Preliminary Data from Phase 1..
13/10/202318:30GLOBEKronos Bio Presents Positive Preliminary Data from Phase 1..
05/10/202314:00EDGAR2Form 8-K - Current report
04/10/202322:05GLOBEKronos Bio To Present Interim Data from Phase 1 Dose..
18/9/202314:00EDGAR2Form 8-K - Current report
17/8/202314:00EDGAR2Form 8-K - Current report
17/8/202314:00GLOBEKronos Bio Announces Departure of Chief Financial Officer..
08/8/202322:05GLOBEKronos Bio Reports Recent Business Progress and..
08/8/202322:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:03EDGAR2Form 8-K - Current report
07/7/202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/7/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202314:00GLOBEKronos Bio Names Marc Besman, Ph.D., as Senior Vice..
01/6/202322:05GLOBEKronos Bio Announces Participation in Upcoming Investor..
10/5/202322:05GLOBEKronos Bio Reports Recent Business Progress and..
Apertura: 1,01 Min: 1,00 Max: 1,06
Chiusura: 1,00

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network